RARA CRAFT DATABASE for FDA Medical Devices
510(k)K252323

FDA DEVICE FACTS

cobas pulse blood glucose monitoring system

Roche Diagnostics

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 12, 2026PRODUCT CODEPZICLINICAL AREAClinical Laboratory

Indications for use

The cobas pulse blood glucose monitoring system consists of the cobas pulse instrument and cobas GLU test strips. It is intended for in vitro diagnostic point-of-care multiple-patient use in professional healthcare settings, including patients receiving intensive medical intervention or therapy. The cobas GLU test strips quantitatively measure glucose in venous whole blood, arterial whole blood, neonatal arterial whole blood, or neonatal heel-stick whole blood on the cobas pulse system. For neonatal heel-stick samples, the system should be used only with single-use auto-disabling lancing devices. The system is not intended for capillary finger-stick, neonatal cord-blood, or neonatal venous specimens. It is not intended for diabetes screening or diagnosis, but is indicated for determining dysglycemia.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026